by Steve MacDonald, Granite Grok
Remember when the media and public health machinery exclaimed that “research” out of Brazil published in the New England Journal of Medicine proved Ivermectin was ineffective? The together trial did prove something, but not what the experts claimed.
It proved that interested parties (Pfizer, Merck, Bill & Melinda Gates Foundation) get a study published that said whatever they needed, not that this was new or news, but the media left all that out.
Some doctors continue to look for the best outcomes for patients, so Brazil is back. This time, researchers compiled data from over 88,000 individuals.
Regular use of ivermectin as prophylaxis for COVID-19 led up to 92% reduction in COVID-19 mortality rate in a dose-response manner: results of a prospective observational study of a strictly controlled population of 88,012 subjects among 223,128 participants.
In the interest of public health, if that were a priority, any study that suggested proof of efficacy would be hailed as a positive step, especially for an FDA-licensed product with decades of documented safe use in people. One that even the WHO’s compiled research data from all studies suggests gets the best results.